Key result
Combined inhibition of catalase and ADH/CYP2E1 significantly attenuated ethanol-induced myocardial dysfunction and oxidative stress in conscious female rats.
Why the study?
Does combined catalase and ADH inhibition ameliorate ethanol-induced myocardial dysfunction and oxidative stress in conscious female rats?
Does combined catalase and ADH inhibition ameliorate ethanol-induced myocardial dysfunction and oxidative stress in conscious female rats?
Ethanol oxidative metabolism plays a pivotal role in ethanol-evoked LV oxidative stress and dysfunction, which can be attenuated by combined ADH and catalase inhibition.
Answers are grounded in this paper and cite their sources.
Warrants no clinical practice change; leaves open targeted investigation of oxidative pathways in alcohol cardiomyopathy.
BACKGROUND: Ethanol (EtOH)-evoked oxidative stress, which contributes to myocardial dysfunction in proestrus rats, is mediated by increases in NADPH oxidase (Nox) activity, malondialdehyde (MDA), and ERK1/2 phosphorylation. Whether these biochemical responses, which are triggered by alcohol-derived acetaldehyde in noncardiac tissues, occur in proestrus rats' hearts remains unknown. Therefore, we elucidated the roles of alcohol dehydrogenase (ADH), cytochrome P4502E1 (CYP2E1), and catalase, which catalyze alcohol oxidation to acetaldehyde, in these alcohol-evoked biochemical and hemodynamic responses in proestrus rats. METHODS: Conscious proestrus rats prepared for measurements of left ventricular (LV) function and blood pressure (BP) received EtOH (1.5 g/kg, intravenous [i.v.] infusion over 30 minutes) or saline 30 minutes after an ADH and CYP2E1 inhibitor, 4-methylpyrazole (4-MP) (82 mg/kg, intraperitoneal), a catalase inhibitor, 3-AT (0.5 g/kg, i.v.), their combination, or vehicle. LV function and BP were monitored for additional 60 minutes after EtOH or saline infusion before collecting the hearts for ex vivo measurements of LV reactive oxygen species (ROS), Nox activity, MDA, and ERK1/2 phosphorylation. RESULTS: and LV developed pressure) and BP, and increased cardiac Nox activity, ROS and MDA levels, and ERK1/2 phosphorylation. Either inhibitor partially, and their combination significantly, attenuated these responses despite the substantially higher blood EtOH level, and the increased cardiac oxidative stress and reduced BP caused by 3-AT alone or with 4-MP. The inhibitors reduced cardiac MDA level and reversed EtOH effect on cardiac and plasma MDA. CONCLUSIONS: EtOH oxidative metabolism plays a pivotal role in the EtOH-evoked LV oxidative stress and dysfunction in proestrus rats. Notably, catalase inhibition (3-AT) caused cardiac oxidative stress and hypotension.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2017) studied Ethanol-induced myocardial dysfunction. Combined catalase (3-AT) and ADH/CYP2E1 (4-MP) inhibition prior to ethanol vs. Vehicle was evaluated on Left ventricular function, blood pressure, and cardiac oxidative stress markers. Combined inhibition of catalase and ADH/CYP2E1 significantly attenuated ethanol-induced myocardial dysfunction and oxidative stress in conscious female rats.
Synapse has enriched 10 related papers. Consider them for comparative context: